Sterne Agee Upgrades Imperva (IMPV) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/9/2026
- S&P 500 ends down after Trump says Iran deal is 'over'
- Oil settles at multi-week high as US-Iran truce buckles under fresh hostilities
- Nvidia is up just 3% YTD while SOX surges 82% — what’s holding it back?
- BofA says S&P 500 technicals point to corrective Q3
- Alibaba rallies 12% after report of narrowing losses sparks pre-earnings optimism
- Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
- Crude Inventory Rose 3 Million Barrels Last Week - EIA
- GameStop stockholders approve share count increase to 2.5 billion
- AI bubble fears mount as Zuckerberg admits agent delays and Burry shorts sector
- S&P 500 ends down after Trump says Iran deal is 'over'
Deutsche Bank Downgrades Imperva (IMPV) to Hold
April 10, 2014 8:55 AM EDTDeutsche Bank downgraded Imperva (NYSE: IMPV) from Buy to Hold with a price target of $40.00 (from $60.00).
Analyst Nandan Amladi said, "IMPV negatively preannounced its Q114 numbers, guiding down its Rev and EPS. It now expects Rev/ EPS of $31.0m - $31.5m / ($0.40) ($0.44) vs prior guide of $36.0 - $37.0m/... More
Oppenheimer Downgrades Imperva (IMPV) to Perform
April 10, 2014 6:25 AM EDTOppenheimer downgraded Imperva (NYSE: IMPV) from Outperform to Perform and removed their $65 price target following the company's Q1 warning.
Analyst Shaul Eyal siad, "Our downgrade is driven by: 1.) negative 1Q pre-announcement driven mainly by US weakness; 2.) increased competition for >$100K deals; 3.) our... More
FireEye (FEYE), Fortiet (FTNT) Dip on Imperva (IMPV) Warning
April 9, 2014 4:28 PM EDTFireEye, Inc. (NASDAQ: FEYE) and Fortinet (Nasdaq: FTNT) are lower following preliminary Q1 results from peer Imperva, Inc. (NYSE: IMPV).
After markets closed, Imperva said that it expected Q1 reveneu of $31 to $31.5... More
Imperva, Inc. (IMPV) Warns for Q1
April 9, 2014 4:08 PM EDTImperva, Inc. (NYSE: IMPV) expects to report total revenue for the first quarter of 2014 in the range of $31.0 million to $31.5 million compared to the companys prior guidance of total revenue in the range of $36.0 million to $37.0 million. The consensus is $36.7 million.
Imperva also expects to report non-GAAP operating loss in the first quarter of 2014 in the range of $(9.5) million to $(10.5) million, and expects to report non-GAAP net loss per share attributable to Imperva stockholders in the range of $(0.40) to $(0.44) using approximately 25.2 million... More
